Townsquare Capital LLC Buys 3,487 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Townsquare Capital LLC boosted its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHIFree Report) by 14.4% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 27,722 shares of the real estate investment trust’s stock after buying an additional 3,487 shares during the period. Townsquare Capital LLC’s holdings in Omega Healthcare Investors were worth $1,128,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of OHI. Assetmark Inc. grew its position in shares of Omega Healthcare Investors by 1.7% during the third quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust’s stock valued at $48,492,000 after purchasing an additional 19,542 shares in the last quarter. Daiwa Securities Group Inc. grew its holdings in Omega Healthcare Investors by 317.7% during the 3rd quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock valued at $160,739,000 after buying an additional 3,003,845 shares in the last quarter. Caxton Associates LP bought a new stake in Omega Healthcare Investors in the 2nd quarter worth approximately $1,652,000. Van ECK Associates Corp raised its holdings in shares of Omega Healthcare Investors by 15.4% during the 3rd quarter. Van ECK Associates Corp now owns 100,145 shares of the real estate investment trust’s stock worth $4,167,000 after acquiring an additional 13,367 shares in the last quarter. Finally, Citigroup Inc. boosted its position in shares of Omega Healthcare Investors by 20.1% during the 3rd quarter. Citigroup Inc. now owns 351,529 shares of the real estate investment trust’s stock valued at $14,307,000 after acquiring an additional 58,950 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Omega Healthcare Investors

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. The trade was a 10.96 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. The trade was a 36.19 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on OHI shares. Wells Fargo & Company reaffirmed an “overweight” rating and set a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Truist Financial upped their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th. Scotiabank lifted their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. BMO Capital Markets upped their price objective on Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research report on Monday, October 7th. Finally, Royal Bank of Canada lifted their target price on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a report on Monday, November 11th. Seven analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $40.00.

Check Out Our Latest Analysis on Omega Healthcare Investors

Omega Healthcare Investors Price Performance

OHI opened at $39.81 on Tuesday. The business has a fifty day moving average of $40.59 and a 200 day moving average of $37.46. The stock has a market cap of $10.75 billion, a P/E ratio of 29.27, a PEG ratio of 1.26 and a beta of 0.99. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. Omega Healthcare Investors, Inc. has a 52-week low of $27.53 and a 52-week high of $44.42.

Omega Healthcare Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were issued a dividend of $0.67 per share. The ex-dividend date was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.73%. Omega Healthcare Investors’s payout ratio is 197.06%.

Omega Healthcare Investors Company Profile

(Free Report)

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.

Featured Stories

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHIFree Report).

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.